The stimulation of the CREB pathway by XESAD suggests the possibility that XEASD may be effective in treating obsessive compulsive disorder, which occurs in a large percentage of patients with TS (Buzan et al., 2000; Como et al., 2005; Arora et al., 2013). This evidence concerns the gene CREB1 and obsessive-compulsive disorder.